1-3 of 3
Daniel Starczynowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Clinical Trials & Observations
Edward J. Gorak, Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu, Rafael Bejar, Steven D. Gore, Steven H. Kroft, Alexandra Harrington, Wael Saber, Daniel Starczynowski, Dana E. Rollison, Ling Zhang, Lynn Moscinski, Steffanie Wilson, Jason Thompson, Christine Borchert, Seth Sherman, Donnie Hebert, Mary Ellen Walker, Eric Padron, Amy E. DeZern, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6120–6129.
https://doi.org/10.1182/bloodadvances.2023010061
Published: 2023
Includes: Supplemental data
Journal Articles

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Clinical Trials & Observations
Maximilian Stahl, Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F. Sanz, David A. Sallman, Valeria Santini, Gail J. Roboz, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Aziz Nazha, Stephen D. Nimer, Ravindra Majeti, Richard F. Little, Steven Gore, Alan F. List, Vijay Kutchroo, Rami S. Komrokji, Tae Kon Kim, Nina Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Peter L. Greenberg, Maria Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Matteo G. Della Porta, Naval G. Daver, Jane E. Churpek, Hetty E. Carraway, Andrew M. Brunner, Uma Borate, John M. Bennett, Rafael Bejar, Jacqueline Boultwood, Sanam Loghavi, Jan Philipp Bewersdorf, Uwe Platzbecker, David P. Steensma, Mikkael A. Sekeres, Rena J. Buckstein, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2709–2714.
https://doi.org/10.1182/bloodadvances.2022008747
Published: 2023
Journal Articles

Momelotinib is a highly potent inhibitor of FLT3-mutant AML

Mohammad Azhar, Zachary Kincaid, Meenu Kesarwani, Arhama Ahmed, Mark Wunderlich, Tahir Latif, Daniel Starczynowski, Mohammad Azam
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1186–1192.
https://doi.org/10.1182/bloodadvances.2021004611
Published: 2022
Includes: Supplemental data